Revenue: The sum of all revenue fields included for a company's operating activities.
Zenas BioPharma, Inc. (ZBIO) Revenue data is not available for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-80.99M |
|
-- |
|
-- |
|
$77.35M |
|
$-77.35M |
|
$-3.64M |
|
$-80.99M |
|
$-80.99M |
|
$-80.99M |
|
$-80.99M |
|
$-80.99M |
|
$-80.99M |
|
$-77.35M |
|
$-77.34M |
|
55.62M |
|
55.62M |
|
$-1.46 |
|
$-1.46 |
|
| Balance Sheet Financials | |
$730.16M |
|
$0.03M |
|
$17.52M |
|
$747.68M |
|
$61.16M |
|
$350.62M |
|
$350.69M |
|
$411.85M |
|
$335.83M |
|
$335.83M |
|
$335.83M |
|
62.38M |
|
| Cash Flow Statement Financials | |
$-75.20M |
|
$31.61M |
|
$433.48M |
|
$110.64M |
|
$500.22M |
|
$389.58M |
|
$9.20M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.94 |
|
-- |
|
-- |
|
0.51 |
|
1.04 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-75.20M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-24.12% |
|
-24.12% |
|
-10.83% |
|
-11.80% |
|
$5.38 |
|
$-1.35 |
|
$-1.35 |
|